20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Evolus Inc (EOLS) operates in the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry and is headquartered in Newport Beach, United States with about 353 employees. Its market capitalization is roughly $487 million. In the fiscal year ended 2025-12-31, EOLS reported $297M in revenue and ($52M) in net income.
Evolus, Inc., a performance beauty company, delivers products in the cash-pay aesthetic market in the United States, Canada, Europe, and Australia.
Interactive charts & full statements → Open the EOLS valuation workbench →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | $316M | $297M | $266M | $202M | $149M | $100M | $57M | $35M | $0M | $0M | $0M | $0M |
| Gross Profit | $210M | $193M | $182M | $141M | $90M | $56M | $38M | $27M | $0M | $0M | $0M | $0M |
| Gross Margin % | 66.2% | 64.9% | 68.5% | 69.5% | 60.4% | 56.3% | 67.6% | 77.0% | — | — | — | — |
| Operating Income (EBIT) | ($23M) | ($38M) | ($34M) | ($49M) | ($65M) | ($44M) | ($153M) | ($99M) | ($46M) | ($12M) | ($20M) | ($31M) |
| Operating Margin % | -7.3% | -12.7% | -12.9% | -24.4% | -44.0% | -44.5% | -270.7% | -283.3% | — | — | — | — |
| Net Income | ($34M) | ($52M) | ($50M) | ($62M) | ($74M) | ($47M) | ($163M) | ($90M) | ($47M) | ($4M) | ($20M) | ($31M) |
| Net Margin % | -10.8% | -17.4% | -18.9% | -30.5% | -50.1% | -47.0% | -288.3% | -257.8% | — | — | — | — |
| EBITDA | ($10M) | ($23M) | ($25M) | ($42M) | ($54M) | ($39M) | ($145M) | ($92M) | ($46M) | ($12M) | ($20M) | ($31M) |
| Earnings Per Share (EPS) | $-0.53 | $-0.80 | $-0.81 | $-1.08 | $-1.33 | $-0.94 | $-4.83 | $-3.19 | $-1.92 | $-0.19 | $-1.08 | $-1.67 |
| Shares Outstanding (M) | 66M | 64M | 62M | 57M | 56M | 50M | 34M | 28M | 24M | 24M | 19M | 19M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $84M | $73M | $90M | $69M | $69M | $69M | $79M | $61M |
| Gross Profit | $57M | $47M | $59M | $46M | $45M | $47M | $50M | $43M |
| Gross Margin % | 68.0% | 64.8% | 65.7% | 66.5% | 65.3% | 68.1% | 63.8% | 70.2% |
| Operating Income (EBIT) | ($5M) | ($7M) | $0M | ($12M) | ($10M) | ($15M) | ($2M) | ($15M) |
| Operating Margin % | -5.4% | -9.4% | -0.3% | -16.7% | -14.7% | -22.1% | -2.9% | -25.3% |
| Net Income | ($8M) | ($11M) | $0M | ($16M) | ($17M) | ($19M) | ($7M) | ($19M) |
| Net Margin % | -9.6% | -14.6% | 0.1% | -22.8% | -24.7% | -27.6% | -8.6% | -31.4% |
| EBITDA | ($4M) | ($4M) | $7M | ($10M) | ($8M) | ($13M) | $1M | ($13M) |
| Earnings Per Share (EPS) | $-0.12 | $-0.16 | $0.00 | $-0.24 | $-0.27 | $-0.30 | $-0.11 | $-0.30 |
| Shares Outstanding (M) | 66M | 65M | 64M | 65M | 65M | 64M | 63M | 63M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($15M) | ($42M) | ($18M) | ($34M) | ($85M) | ($33M) | ($58M) | ($93M) | ($26M) | ($13M) | ($13M) | ($36M) |
| Capital Expenditures (CapEx) | $7M | $8M | $1M | $2M | $3M | $1M | $3M | $5M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($23M) | ($51M) | ($19M) | ($36M) | ($88M) | ($34M) | ($61M) | ($98M) | ($26M) | ($13M) | ($13M) | ($36M) |
| FCF Margin % | -7.1% | -17.1% | -7.3% | -17.6% | -59.1% | -34.5% | -107.9% | -280.5% | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($4M) | ($10M) | $13M | ($15M) | ($25M) | ($16M) | $5M | ($6M) |
| Capital Expenditures (CapEx) | $1M | $2M | $2M | $2M | $2M | $2M | $1M | $1M |
| Free Cash Flow (FCF) | ($5M) | ($12M) | $11M | ($17M) | ($27M) | ($17M) | $3M | ($7M) |
| FCF Margin % | -5.7% | -15.9% | 11.8% | -24.4% | -39.0% | -25.5% | 4.4% | -11.7% |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 | 2017-12-31 | 2016-12-31 | 2015-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $248M | $226M | $233M | $189M | $178M | $257M | $209M | $240M | $172M | $152M | $77M | $81M |
| Cash & Cash Equivalents | $45M | $54M | $87M | $63M | $54M | $146M | $103M | $110M | $93M | $0M | $0M | $4M |
| Total Liabilities | $279M | $249M | $227M | $210M | $159M | $176M | $282M | $161M | $87M | $228M | $85M | $69M |
| Total Debt (Short + Long-Term) | $159M | $149M | $123M | $122M | $73M | $72M | $135M | $93M | $17M | $211M | $60M | $46M |
| Total Shareholders' Equity | ($31M) | ($23M) | $6M | ($21M) | $18M | $82M | ($73M) | $79M | $84M | ($76M) | ($7M) | $12M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive EOLS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms